PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Key Laboratory for Molecular Diagnosis of Hubei Province, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei, China.\', \'Department of Pain, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei, China.\', \'Department of Information, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei, China.\', \'Department of Endocrinology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, Hubei, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamacardio.2020.1624
?:doi
?:hasPublicationType
?:journal
  • JAMA cardiology
is ?:pmid of
?:pmid
?:pmid
  • 32324209
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.551
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all